CMV blood test to guide treatment after organ transplant
Part of Infections clinical trials.
This study uses a blood test (QuantiFERON-CMV) to help decide whether people with a silent (no symptoms) CMV infection after a solid organ transplant need treatment. If you have a low-to-moderate level of CMV in your blood without fever or organ issues, this trial may help your doctor choose the safest approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have received a heart, kidney, liver, or lung transplant.
- You have a CMV viral load between 1,000 and 15,000 IU/mL (from a blood test) without fever or organ problems.
- This CMV occurred within 2 years after transplant (or within 2 years after stopping CMV prevention medicine).
- You are not currently on any antiviral medication for herpes or CMV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how CMV (a common virus) affects the immune system in people who get a kidney transplant or have CMV after transplant. It may help doctors understand and manage CMV better.
This study looks at how to prevent and monitor a virus called CMV after a lung transplant. It is for adults who are not carrying CMV themselves, but who receive lungs from donors who are CMV-positive, and it may help tailor safer follow-up care after transplant.
This study looks at patients who had a solid organ transplant in Argentina and later developed a CMV infection that is hard to treat. It aims to understand these infections better, which could help improve care for future patients.
This trial tests whether adding a specific immunosuppressive drug called everolimus can help treat cytomegalovirus (CMV)—a common viral infection that occurs after organ transplants. If you've had an organ transplant and developed a CMV infection, this study may help your medical team find better ways to manage it.
This trial tests whether using a blood test that measures your immune system's ability to fight CMV (a common virus) can guide when to stop anti-CMV drugs after a lung transplant, aiming to prevent the virus from causing disease.
This trial tests whether giving CMV immunoglobulin (an antibody medicine) after transplant can help prevent a serious CMV infection in people who receive a kidney or liver from a CMV-positive donor. You might be eligible if you are getting one of these transplants and are at high risk for CMV.
Hear when a new Cytomegalovirus Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.